Cell Therapy with Encapsulated Xenogeneic Tumor Cells Secreting β-Endorphin for Treatment of Peripheral Pain

The purpose of this study was to assess whether xenogeneic tumor cells secreting β-endorphin and immunologically isolated in polymer capsules could survive and continue to reduce pain when transplanted into the spinal cerebro-spinal fluid (CSF) space of rats. Also, a silicone container for polymer c...

Full description

Bibliographic Details
Main Authors: Youichi Saitoh, Takuyu Taki, Norio Arita, Takanori Ohnishi, Toru Hayakawa
Format: Article
Language:English
Published: SAGE Publishing 1995-01-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/096368979500401S05
_version_ 1818342344101986304
author Youichi Saitoh
Takuyu Taki
Norio Arita
Takanori Ohnishi
Toru Hayakawa
author_facet Youichi Saitoh
Takuyu Taki
Norio Arita
Takanori Ohnishi
Toru Hayakawa
author_sort Youichi Saitoh
collection DOAJ
description The purpose of this study was to assess whether xenogeneic tumor cells secreting β-endorphin and immunologically isolated in polymer capsules could survive and continue to reduce pain when transplanted into the spinal cerebro-spinal fluid (CSF) space of rats. Also, a silicone container for polymer capsules was designed for the clinical application of this method of cell therapy. The mouse tumor cell lines, proopiomelanocortin gene transfected Neuro2A which secrete β-endorphin, were enclosed in polymer capsules at a density of 5 x 10 6 /mL, and transplanted into the spinal CSF space from the occipito-atlantal junction of male Sprague-Dawley rats. Three analgesiometric tests —the tail pinch test, the hot plate test, and electrical stimulation test — showed that the rats with encapsulated Neuro2A (n = 6) were significantly less sensitive to pain after transplantation than control animals (n = 8). The analgesia induced by the encapsulated cells secreting β-endorphin was attenuated by the opiate antagonist naloxone. Morphological study revealed that the encapsulated cells survived for 1 mo after transplantation into the CSF space. An in vitro experiment on cultured capsules (3 cm long) with a silicone container (Kaneka Medics Co) showed that the encapsulated Neuro2A (5 x 10 6 mL) could secrete peptides for 1 mo. The results of this study indicate that immunologically isolated xenogeneic tumor cells can secrete opiate in the CSF space, and that a silicone container may help the application of this method to the treatment of cancer pain.
first_indexed 2024-12-13T16:13:11Z
format Article
id doaj.art-b8c6e14b45d44f47925cee88e043ba5f
institution Directory Open Access Journal
issn 0963-6897
1555-3892
language English
last_indexed 2024-12-13T16:13:11Z
publishDate 1995-01-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-b8c6e14b45d44f47925cee88e043ba5f2022-12-21T23:38:53ZengSAGE PublishingCell Transplantation0963-68971555-38921995-01-01410.1177/096368979500401S05Cell Therapy with Encapsulated Xenogeneic Tumor Cells Secreting β-Endorphin for Treatment of Peripheral PainYouichi Saitoh0Takuyu Taki1Norio Arita2Takanori Ohnishi3Toru Hayakawa4Department of Neurosurgery, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565, JapanDepartment of Neurosurgery, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565, JapanDepartment of Neurosurgery, Kinki University Medical School, 377-2 Ohnohigashi, Sayama, Osaka 589, JapanDepartment of Neurosurgery, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565, JapanDepartment of Neurosurgery, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565, JapanThe purpose of this study was to assess whether xenogeneic tumor cells secreting β-endorphin and immunologically isolated in polymer capsules could survive and continue to reduce pain when transplanted into the spinal cerebro-spinal fluid (CSF) space of rats. Also, a silicone container for polymer capsules was designed for the clinical application of this method of cell therapy. The mouse tumor cell lines, proopiomelanocortin gene transfected Neuro2A which secrete β-endorphin, were enclosed in polymer capsules at a density of 5 x 10 6 /mL, and transplanted into the spinal CSF space from the occipito-atlantal junction of male Sprague-Dawley rats. Three analgesiometric tests —the tail pinch test, the hot plate test, and electrical stimulation test — showed that the rats with encapsulated Neuro2A (n = 6) were significantly less sensitive to pain after transplantation than control animals (n = 8). The analgesia induced by the encapsulated cells secreting β-endorphin was attenuated by the opiate antagonist naloxone. Morphological study revealed that the encapsulated cells survived for 1 mo after transplantation into the CSF space. An in vitro experiment on cultured capsules (3 cm long) with a silicone container (Kaneka Medics Co) showed that the encapsulated Neuro2A (5 x 10 6 mL) could secrete peptides for 1 mo. The results of this study indicate that immunologically isolated xenogeneic tumor cells can secrete opiate in the CSF space, and that a silicone container may help the application of this method to the treatment of cancer pain.https://doi.org/10.1177/096368979500401S05
spellingShingle Youichi Saitoh
Takuyu Taki
Norio Arita
Takanori Ohnishi
Toru Hayakawa
Cell Therapy with Encapsulated Xenogeneic Tumor Cells Secreting β-Endorphin for Treatment of Peripheral Pain
Cell Transplantation
title Cell Therapy with Encapsulated Xenogeneic Tumor Cells Secreting β-Endorphin for Treatment of Peripheral Pain
title_full Cell Therapy with Encapsulated Xenogeneic Tumor Cells Secreting β-Endorphin for Treatment of Peripheral Pain
title_fullStr Cell Therapy with Encapsulated Xenogeneic Tumor Cells Secreting β-Endorphin for Treatment of Peripheral Pain
title_full_unstemmed Cell Therapy with Encapsulated Xenogeneic Tumor Cells Secreting β-Endorphin for Treatment of Peripheral Pain
title_short Cell Therapy with Encapsulated Xenogeneic Tumor Cells Secreting β-Endorphin for Treatment of Peripheral Pain
title_sort cell therapy with encapsulated xenogeneic tumor cells secreting β endorphin for treatment of peripheral pain
url https://doi.org/10.1177/096368979500401S05
work_keys_str_mv AT youichisaitoh celltherapywithencapsulatedxenogeneictumorcellssecretingbendorphinfortreatmentofperipheralpain
AT takuyutaki celltherapywithencapsulatedxenogeneictumorcellssecretingbendorphinfortreatmentofperipheralpain
AT norioarita celltherapywithencapsulatedxenogeneictumorcellssecretingbendorphinfortreatmentofperipheralpain
AT takanoriohnishi celltherapywithencapsulatedxenogeneictumorcellssecretingbendorphinfortreatmentofperipheralpain
AT toruhayakawa celltherapywithencapsulatedxenogeneictumorcellssecretingbendorphinfortreatmentofperipheralpain